🇺🇸 PTGX — Protagonist Therapeutics, Inc.

Salud Compra fuerte
← Volver

Precio actual

140,24 USD

Máx. histórico

158,62

78 días

Caída desde máximo

-11,59%

Rango 52 semanas

75,44 – 160,81

Variación hoy

+0,62%

Cierre anterior

139,37

Rango de hoy

139,91 – 144,27

Volumen hoy

673.087

Peor caída histórica

-85,79%

01/09/2021 → 13/06/2022

Recuperado en 1001 días

Volatilidad anualizada ⓘ

89,34%

Información
Nombre completo
Protagonist Therapeutics, Inc.
Divisa
USD
Mercado
NasdaqGM
Sector
Salud
Industria
Biotechnology
Empleados
141
PER ⓘ
136,16 (puede no estar actualizado)
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
178,57 USD (puede no estar actualizado)
Primera cotización
11/08/2016
Precio actualizado
hace 6 horas
Sobre la empresa

Protagonist Therapeutics, Inc. operates as a discovery and development company in the United States. It develops Icotyde, a first-in-class investigational targeted oral peptide for the treatment of adults and pediatric patients 12 years of age and older with moderate-to-severe plaque psoriasis; and Rusfertide, a first-in-class investigational injectable mimetic of the natural hormone hepcidin in Phase 3 development for the treatment of the rare blood disorder polycythemia vera. The company is also developing PN-881, a potential best-in-class oral peptide IL-17 antagonist, for the treatment of immune-mediated skin diseases in Phase 1 clinical trials; PN-477 and PN-458, which are development candidates for the treatment of obesity; PN-8047, an orally administered hepcidin functional mimetic small molecule; L-4R alpha antagonist for the treatment of atopic dermatitis and moderate-to-severe asthma; and amylinR-based oral and subcutaneous mono- and poly-agonists for the treatment of obesity. Protagonist Therapeutics, Inc. was incorporated in 2006 and is headquartered in Newark, California.

Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
17/02/2026 81,07 83,13 80,40 82,46 +1,19% 3,37% 364.700
13/02/2026 81,99 84,06 80,59 81,49 -0,54% 4,23% 428.900
12/02/2026 84,07 84,72 81,56 81,93 -1,87% 3,76% 352.500
11/02/2026 83,46 84,82 80,99 83,49 -0,46% 4,59% 350.200
10/02/2026 83,00 84,90 82,65 83,88 +0,67% 2,72% 442.600
09/02/2026 83,47 83,90 82,21 83,32 -1,38% 2,02% 322.000
06/02/2026 82,11 85,05 81,55 84,49 +4,74% 4,26% 812.800
05/02/2026 83,62 85,43 80,20 80,67 -3,16% 6,25% 457.100
04/02/2026 85,59 85,60 81,00 83,30 -2,68% 5,37% 1.077.500
03/02/2026 83,09 86,10 82,88 85,59 +3,06% 3,87% 769.400
02/02/2026 81,80 84,55 81,14 83,05 +1,53% 4,17% 1.414.700
30/01/2026 79,77 82,56 78,75 81,80 +2,60% 4,78% 1.174.000
29/01/2026 81,39 82,49 77,70 79,73 -2,48% 5,89% 952.700
28/01/2026 82,45 83,69 80,00 81,76 -1,59% 4,48% 777.200
27/01/2026 82,00 83,87 82,00 83,08 +0,95% 2,28% 507.800
26/01/2026 82,53 84,32 81,94 82,30 -0,96% 2,87% 529.200
23/01/2026 84,62 85,50 82,67 83,10 -1,99% 3,35% 569.300
22/01/2026 82,83 85,20 80,65 84,79 +1,07% 5,49% 609.100
21/01/2026 82,51 83,96 80,27 83,89 +0,56% 4,47% 1.086.100
20/01/2026 81,16 83,63 79,87 83,42 +1,74% 4,63% 901.300
16/01/2026 84,51 84,67 81,47 81,99 -3,26% 3,79% 664.700
15/01/2026 84,60 87,44 84,33 84,75 -0,56% 3,68% 839.300
14/01/2026 80,85 85,30 80,47 85,23 +4,76% 5,97% 1.052.600
13/01/2026 79,88 82,74 79,64 81,36 +1,38% 3,88% 799.000
12/01/2026 79,49 81,09 78,75 80,25 +0,04% 2,94% 739.800
09/01/2026 80,20 81,40 79,38 80,22 +0,02% 2,52% 983.300
08/01/2026 81,05 82,14 79,22 80,20 -2,60% 3,60% 1.487.700
07/01/2026 82,25 82,69 79,18 82,34 +0,09% 4,27% 1.220.400
06/01/2026 83,25 85,00 81,67 82,27 -2,27% 4,00% 731.000
05/01/2026 87,53 87,53 82,92 84,18 -3,44% 5,27% 1.028.100